Skip to Content

Infanrix hexa – EU/1/00/152/006 – Five batches

10/10/2024
Medicines for human use Direct healthcare professional communication (DHPC)

We wish to advise you that a Direct Healthcare Professional Communication (DHPC) has been issued for five batches of Infanrix hexa, EU/1/00/152/006.

Important Safety Information from GlaxoSmithKline (Ireland) Limited: A packaging issue potentially impacting the sterility of needle softpacks.

Actions required: Discard the needle packs from all affected batches. 

Healthcare Professionals can download a copy of the DHPC in the documents section at the bottom of this webpage. 

Product information

Authorisation holder
GlaxoSmithKline (Ireland) Limited
Authorisation number

EU/1/00/152/006

Serial or batch number and expiry date
A21CE469C, 31-Oct-2027
A21CE460C, 30-Sep-2026
A21CE458B, 31-May-2027
A21CE376A, 28-Feb-2027
A21CE437A, 31-May-2027

Documents

Opens in new window Infanrix hexa - DHPC - 10 Oct 2024 PDF : 295KB | 10/10/2024